obesity drug news today glp-1 2025 As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: “Ozempic feet.” Story🔗below GLP-1 Weight Loss Drug Enforcement

Young, J

Graphical Abstract Keywords: Chronic kidney disease, Diabetic kidney disease, Glucagon-like peptide-1 receptor agonists, Renal impairment, Type 2 diabetes mellitus Plain Language Summary Type 2 diabetes mellitus (T2DM) is a common disorder characterized by insulin resistance and dysfunction of insulin-producing beta cells of the pancreas

Case reports and observational data have noted reductions in thyroid volume and TSH levels in obese individuals treated with GLP-1RAs though the clinical significance is unclear [29]

Diabetes Endocrinol

2017;40(Suppl

Wang XF, Lin X, Li DY, Zhou R, Greenbaum J, Chen YC, et al